Status:

COMPLETED

RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19

Lead Sponsor:

Gordon Saxe

Collaborating Sponsors:

University of California, Los Angeles

University of California, Irvine

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), to treat COVID-19-positiv...

Detailed Description

Despite biomedical advances, medical intervention for COVID-19 is largely limited to vaccinations and supportive care during the later stages of disease. While antiviral, anti-inflammatory, and antima...

Eligibility Criteria

Inclusion

  • Positive COVID-19 diagnosis within the prior 72 hours
  • Age 18 years and older
  • Women of childbearing potential must have a negative urine or serum hCG. Women of childbearing potential must have a negative serum pregnancy test at screening and agree to use contraception throughout the study period.
  • Capable of documenting vitals, symptoms, and study product intake daily and communicating this information to the study team
  • Willing to avoid alcohol, cannabis, and dairy products during the study period.

Exclusion

  • Any of the following symptoms which, according to the CDC, require hospitalization:
  • Trouble breathing
  • Persistent pain or pressure in the chest
  • New confusion or inability to arouse
  • Bluish lips or face
  • Current use of investigational agents to prevent or treat COVID-19
  • Known liver disease (ALT/AST \>3x ULN or diagnosis of cirrhosis)
  • Known renal disease (eGFR \< 60 ml/min) or acute nephritis.
  • Uncontrolled hypertension (SBP\>140 or DBP\>90 while on medications)
  • Pregnant or breastfeeding women

Key Trial Info

Start Date :

December 23 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 4 2022

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT04667247

Start Date

December 23 2020

End Date

May 4 2022

Last Update

August 19 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of California, Los Angeles

Los Angeles, California, United States, 90095

2

University of California, San Diego

San Diego, California, United States, 92093